OBAGI-C RX system NORMAL-oily
OBAGI-C RX SYSTEM
Approved
Approval ID
b31837f7-721f-484e-89d5-4ad84ad0f400
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 26, 2023
Manufacturers
FDA
Obagi Cosmeceuticals LLC
DUNS: 790553353
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
HYDROQUINONE, HOMOSALATE, OCTISALATE AND ZINC OXIDE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code62032-534
Product Classification
G
Generic Name
HYDROQUINONE, HOMOSALATE, OCTISALATE AND ZINC OXIDE
Product Specifications
Effective DateJanuary 26, 2023
FDA Product Classification